---
title: "Telix Pharmaceuticals to host R&D Day for institutional investors and analysts"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294955989.md"
description: "Telix Pharmaceuticals will host an R&D Day in New York City on September 22, 2026, for institutional investors and analysts to discuss pipeline updates. Additionally, a Capital Markets Day is scheduled for Melbourne on November 4, 2026, focusing on strategy, growth outlook, and financial targets."
datetime: "2026-08-05T11:11:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294955989.md)
  - [en](https://longbridge.com/en/news/294955989.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294955989.md)
generator: "portal-rs"
---

# Telix Pharmaceuticals to host R&D Day for institutional investors and analysts

-   Telix Pharmaceuticals will host an R&D Day in New York City on September 22, 2026, scheduled for 8:30 a.m. to 12:30 p.m. EDT. \* The session will outline pipeline and portfolio updates across therapeutics and precision medicine for institutional investors and analysts. \* A Capital Markets Day is set for Melbourne on November 4, 2026, covering strategy, growth outlook, financial targets, and business priorities. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telix Pharmaceuticals Ltd. published the original content used to generate this news brief on August 05, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [TLX.US](https://longbridge.com/en/quote/TLX.US.md)
- [TLX.AU](https://longbridge.com/en/quote/TLX.AU.md)

## Related News & Research

- [Telix Appoints David Gill as Chair | TLX Stock News](https://longbridge.com/en/news/297567288.md)
- [Faron Pharmaceuticals releases H1 2026 results webcast transcript](https://longbridge.com/en/news/297049228.md)
- [Acura Pharmaceuticals delays filing quarterly report amid liquidity concerns](https://longbridge.com/en/news/297049878.md)
- [iShares Core S&P 500 ETF declares Q3 2026 distribution of R$ 0.10 per unit](https://longbridge.com/en/news/297548335.md)
- [Vuxen Group announces availability of FY2025/2026 annual report (May 1, 2025–April 30, 2026)](https://longbridge.com/en/news/297499193.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**